Approval · Notice of Compliance 23984 · 2020
OCREVUS: Notice of Compliance 23984
Issued July 31, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23984
- Date
- July 31, 2020
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OCREVUS | Not yet assigned | — |
Medicinal ingredients
- OCRELIZUMAB 30 MG per ML